Skip to main content
Equibles

DIVERSIFY WEALTH MANAGEMENT, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2030780 SANDY, UT
Back to VRTX Full portfolio

Position in VRTX

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$11,011,510
+$1,084,033 QoQ
Shares Held
22,168
-0.3% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#353
of 1,745 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Derivatives in VRTX

reported options exposure · as of Jun 30, 2026
CallValue
$49,673
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIVERSIFY WEALTH MANAGEMENT, LLC holds $27,989,725 across 15 Biotechnology names. VRTX ranks #1 (39.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
This page 		22,168 $11,011,510
2 ASND
Ascendis Pharma A/S
 11,181 $2,982,196
3 ABVX
Abivax S.A.
 20,817 $2,774,073
4 HALO
Halozyme Therapeutics, Inc.
 33,976 $2,659,301
5 LGND
Ligand Pharmaceuticals Inc
 7,956 $2,514,812
6 ARGX
Argenx SE
 2,197 $2,038,310
7 DBVT
DBV Technologies S.A.
 89,692 $1,470,948
8 REGN
Regeneron Pharmaceuticals, Inc.
 1,211 $755,106

All Filings in VRTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,011,510 22,168
2026-06-30 $49,673 100
2026-03-31 $9,927,477 22,232
2026-03-31 $423 100
2025-12-31 $5,299,778 11,690
2025-09-30 $4,783,490 12,214
2025-06-30 $5,782,257 12,988
2025-03-31 $5,338,837 11,012
2024-12-31 $3,935,587 9,773
2024-09-30 $1,742,189 3,746
2024-06-30 $1,380,849 2,946